Navigation Links
Phase 3 Data Show New Anti-TNF, Golimumab, Significantly Improved Arthritis, Skin and Nail Manifestations in Patients with Psoriatic Arthritis
Date:11/7/2007

n-Janssen.

About Centocor

Centocor is harnessing the power of world-leading research and biomanufacturing to deliver innovative biomedicines that transform patients' lives. Centocor has already brought innovation to the treatment of Crohn's disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, pediatric Crohn's disease and psoriasis.

The world leader in monoclonal antibody production and technology, Centocor has brought critical biologic therapies to patients suffering from debilitating immune disorders. Centocor, Inc. is a wholly owned subsidiary of Johnson & Johnson.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 31, 2006. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result
'/>"/>

SOURCE Centocor Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... , May 20, 2013 Decision ... advisory firms for pharmaceutical and healthcare issues, finds ... therapies offering a greater effect on quality of ... need. Given the high level of subjectivity and ... life, interviewed thought leaders state that it is ...
(Date:5/19/2013)...  Whole-cell pertussis vaccines were more effective at protecting ... recent outbreak, according to a new Kaiser Permanente study ... called DTwP, were available from the 1940s to 1990s, ... to the development of acellular pertussis vaccines, which are ... the United States had switched from whole-cell ...
(Date:5/18/2013)... FRANCISCO , May 18, 2013 ... MadinAmerica.com , Occupy Psychiatry , ... mental health care, announces a social media campaign ... the traditional psychiatric model, which focuses on pathology ... launch coincides with the American Psychiatric Association,s (APA) ...
Breaking Medicine Technology:For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3
... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
(Date:5/21/2013)... -- Air pollution and noise pollution both may ... from Germany suggests. "Many studies have looked ... noise pollution," said Dr. Barbara Hoffmann, a professor ... for Environmental Medicine and lead author of the ... at the same time and found that each ...
(Date:5/21/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) -- ... critically ill patients who have been placed on ventilators, ... according to a new study. Intensive care unit ... choice whenever they liked enjoyed a 36 percent reduction ... music, researchers found. The ICU patients who were ...
(Date:5/21/2013)... -- When it comes to the care of your ... help. New recommendations from a government advisory panel ... preventing tooth decay in the young. The U.S. ... that primary care physicians use fluoride varnish and oral ... children. "Tooth decay is the most common chronic ...
(Date:5/21/2013)... By Steven Reinberg HealthDay Reporter , , MONDAY, ... solution appear to help relieve knee pain and stiffness ... technique -- known as dextrose prolotherapy -- has been ... "alternative" therapy. "Our study suggests very strongly that ... with mild to moderate knee osteoarthritis that hasn,t responded ...
(Date:5/21/2013)... 20 (HealthDay News) -- Although people with implantable ... activities more strenuous than golf or bowling, new ... devices can participate in more vigorous sports. ... be made on an individual basis following a ... their doctor, the researchers from Yale University School ...
Breaking Medicine News(10 mins):Health News:Noise, Dirty Air May Be Double Whammy for the Heart 2Health News:Favorite Music May Ease Anxiety in ICU Patients 2Health News:Favorite Music May Ease Anxiety in ICU Patients 3Health News:Primary Care Docs Should Play Role in Kids' Dental Health, Experts Say 2Health News:Sugar Injections for Knee Arthritis May Ease Pain: Study 2Health News:Sugar Injections for Knee Arthritis May Ease Pain: Study 3Health News:Sports May Be OK With Defibrillator, Study Says 2
... ... mental health illness stereotypes , ... Arlington, VA (PRWEB) October 28, 2009 -- As Halloween approaches, the ... alert" for costumes and other seasonal attractions that feature inaccurate and offensive stereotypes ...
... DENVER, Oct. 28 Many medical practices are struggling. ... making basic business mistakes, according to Andrew Graham, MBA, ... top reasons practices struggle, said Graham. , ... to include goals for revenue generation, customer service, performance ...
... 28 Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ... commercialization of clinical-stage product candidates for central nervous system ... quarter ended September 30, 2009, on Monday, November 2, ... of the release will be disseminated at that time. ...
... Oct. 28 The cutting-edge of assistive technology--including ... showcased at the Assistive Technology Pavilion at Abilities ... 6-8, 2009 at the Cobb Galleria Convention Center. ... caregivers and healthcare professionals are expected to attend ...
... 28 What happens when intended parents cross international borders ... of Mumbai, India-based law firm Menon & Associates ( ... Family Solutions was among the panel speakers on ... Association Section of Family Law recently held in Montreal, Canada. ...
... , NASDAQ: CRME ... /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its ... patient enrolment has begun for the ACT 5 trial, a ... a drug product candidate under development for the rapid conversion ...
Cached Medicine News:Health News:NAMI Issues "Stigma Alert" Over Inaccurate and Offensive Halloween Costumes, Attractions 2Health News:NAMI Issues "Stigma Alert" Over Inaccurate and Offensive Halloween Costumes, Attractions 3Health News:The Top 10 Business Mistakes Made By Physician Practices 2Health News:Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009 2Health News:Experience the Future of Assistive Technology at Abilities Expo on November 6-8, 2009 2Health News:Legislation in India to Address Assisted Reproductive Technology, Egg Donation and Surrogacy 2Health News:Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 2Health News:Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 3Health News:Cardiome And Astellas Announce Initiation Of Patient Enrolment In ACT 5 Trial 4
Anorectal Stylet for LATITUDE® Air-Charged Catheter...
Omnilink Adapter Cable for LATITUDE® Air-Charged Catheter...
Solid State Manometry Catheter Accessory., ,Manometric calibrators are required for calibration of solid state catheters., ,Each type of catheter requires a unique calibrator....
... The ITREL 3 is a battery ... in the U.S., ,Enterra™ Therapy is ... and vomiting associated with gastroparesis when conventional ... of symptons for diabetic or idiopathic patients., ...
Medicine Products: